Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cells: making progress with tumour regression?

Scott N Byrne1, Gary M Halliday

  • 1Department of Medicine (Dermatology), Melanoma and Skin Cancer Research Institute, Sydney Cancer Centre, Royal Prince Alfred Hospital at the University of Sydney, Australia.

Immunology and Cell Biology
|October 31, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semi-Synthesis of Immunogenic Mycobacterial Lipoproteins via Aryl Selenoester-Mediated Expressed Protein Ligation.

Angewandte Chemie (International ed. in English)·2025
Same author

Upper respiratory tract immunization with Pam<sub>2</sub>Cys-adjuvanted spike protein vaccine achieves sterilizing protection against SARS-CoV-2.

Frontiers in immunology·2025
Same author

Narrowband UVB and Solar-Simulated UV Suppress Systemic Immune Responses through Different Mechanisms.

The Journal of investigative dermatology·2025
Same author

Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2.

ACS infectious diseases·2024
Same author

Exposure to solar ultraviolet radiation establishes a novel immune suppressive lipidome in skin-draining lymph nodes.

Frontiers in immunology·2023
Same author

Circulating CCR6<sup>+</sup>ILC proportions are lower in multiple sclerosis patients.

Clinical & translational immunology·2022
Same journal

Ancestry Matters in Decoding Immunity.

Immunology and cell biology·2026
Same journal

Improving COVID-19 Vaccine Uptake Among Ethnic Minority Communities in Wales: A Community-Based Approach.

Immunology and cell biology·2026
Same journal

4-1BB Expression and Signaling Regulates MAIT Cell Activation and Effector Functions.

Immunology and cell biology·2026
Same journal

Highlights of 2025: Advances in the T-Cell Regulation of Germinal Center Response.

Immunology and cell biology·2026
Same journal

The Role of the IL-33/ST2 Axis in Nervous System Development and Diseases.

Immunology and cell biology·2026
Same journal

Bridging Science and Society: Public Engagement as a Catalyst for Infectious Disease Control and Prevention.

Immunology and cell biology·2026
See all related articles

Dendritic cells (DCs) show promise for cancer immunotherapy. However, understanding how tumors affect these immune cells is crucial for developing effective DC-based treatments.

Area of Science:

  • Immunology
  • Cancer Research
  • Cell Biology

Background:

  • Dendritic cells (DCs) are potent immune activators and investigated as adjuvants for cancer immunotherapy.
  • The interaction between tumor cells and tumor-infiltrating dendritic cells (TDCs) is complex and not fully understood.
  • Different DC subsets possess distinct immunological functions, further complicating their role in the tumor microenvironment.

Purpose of the Study:

  • To review recent advances in understanding dendritic cell (DC) phenotype and function.
  • To explore the intricate relationship between tumor cells and various tumor-infiltrating DC subtypes.
  • To highlight knowledge gaps regarding the effects of tumors on DC function for immunotherapy development.

Main Methods:

  • Literature review of recent scientific publications.

Related Experiment Videos

  • Analysis of studies investigating dendritic cell phenotype and function.
  • Examination of research on tumor-DC interactions.

    • Main Results:

    • Tumor cells significantly impact dendritic cell (DC) function, although the precise mechanisms are still under investigation.
    • The complex interplay between different tumor types and distinct DC subsets influences treatment efficacy.
    • Current understanding of tumor-induced DC modulation is insufficient for optimal immunotherapy design.

    Conclusions:

    • Further research is essential to elucidate the multifaceted effects of tumors on dendritic cells (DCs).
    • A deeper comprehension of DC behavior within the tumor microenvironment is critical for advancing DC-based cancer immunotherapy.
    • Bridging the knowledge gap in tumor-DC interactions will pave the way for more effective cancer treatments.